Results 171 to 180 of about 73,504 (266)

Cost-Effectiveness of the Pneumococcal Vaccine in the Adult Population: A Systematic Review. [PDF]

Healthcare (Basel)
Vo NX, Pham HL, Bui UM, Ho HT, Bui TT.
europepmc   +1 more source

Immunogenicity and Safety of the Higher-Valent Pneumococcal Conjugate Vaccine vs the 13-Valent Pneumococcal Conjugate Vaccine in Older Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials [PDF]

Thundon Ngamprasertchai, Narisa Ruenroegnboon, Rattagan Kajeekul   +2 more
openalex   +1 more source

Assessment of naturally acquired IgG antibodies to pneumococcal vaccine serotypes in healthy and type 2 diabetic adults in India. [PDF]

Clin Exp Vaccine Res
Shincy MR, Akhila MM, Vandana G, Geetha N, Rajashekaraiah V, Ravikumar KL.   +5 more
europepmc   +1 more source

A phase 3 randomized trial of the safety and immunogenicity of 20-valent pneumococcal conjugate vaccine in adults ≥ 60 years of age in Japan, South Korea, and Taiwan

Miwa Haranaka, Joon Young Song, Kuo‐Chin Huang, Richard de Solom, Masako Yamaji, Kathleen McElwee, Mary Kline, Masakazu Aizawa, Yahong Peng, Ingrid L. Scully, Osamu Kogawara, William C. Gruber, Daniel A. Scott, Wendy Watson   +13 more
openalex   +1 more source

Triptych of the Hermit Saints: pneumococcal polysaccharide vaccines for the elderly

, 2018
Ger T. Rijkers, Laura I. Yousif, Simone M.C. Spoorenberg, Frans J. van Overveld   +3 more
openalex   +2 more sources

Specific Features of Immune Response in Patients with Different Asthma Endotypes Following Immunization with a Conjugate Pneumococcal Vaccine. [PDF]

Vaccines (Basel)
Kostinov AM, Konishcheva AY, Protasov AD, Kostinov MP, Polishchuk VB, Zhestkov AV, Yastrebova NE, Kostinova AM, Musagulova ZS, Prutskova EV.   +9 more
europepmc   +1 more source

New vaccines against pneumonia: Investigating protein-specific immune responses to Streptococcus pneumoniae using Experimental Human Pneumococcal Carriage

, 2017
Jessica Owugha
openalex   +1 more source

Standardized study performance, quality assurance, and quality control in a cluster-randomized trial: the Pneumococcal Vaccine Schedules trial. [PDF]

Trials
Osei I, Young B, Sarwar G, Olatunji YA, Hossain I, Lobga BG, Wutor BM, Adefila W, Mendy E, Adeshola B, Isa YS, Olawale YA, Lamin KM, Nyimanta E, Baldeh B, Nyassi A, Drammeh MM, Ousman B, Molfa M, Salaudeen R, Mackenzie GA.   +20 more
europepmc   +2 more sources

Correction to: Pneumococci remain the main cause of complicated pediatric pneumonia in the post-pandemic era despite extensive pneumococcal vaccine use. [PDF]

Pneumonia (Nathan)
Gomes-Silva J, Pinho MD, Friaes A, Ramirez M, Melo-Cristino J, Silva-Costa C, Portuguese Group for the Study of Streptococcal Infections, Portuguese Study Group of Invasive Pneumococcal Disease of the Pediatric Infectious Disease Society.   +7 more
europepmc   +1 more source

State of pneumococcal vaccine immunity. [PDF]

Hum Vaccin Immunother
Akkoyunlu M.
europepmc   +1 more source